Accuracy of the first fully automated method for anti-cardiolipin and anti-β2 glycoprotein i antibody detection for the diagnosis of Antiphospholipid syndrome

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 21-27

  Villalta, D ^a   Alessio, M G ^b   Tampoia, M ^c   Da Re, A ^a   Stella, S ^a   Da Re, M ^a   Tozzoli, R ^d   Bizzaro, N ^d  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c POLICLINICO   (Italy)

^d Civil Hospital   (Italy)

Author keywords

Anti 2 glycoprotein I auto antibodies (anti 2 GPI); Anticardiolipin auto antibodies (aCL); Antiphospholipid auto antibodies (aPL); Antiphospholipid syndrome (APS); Diagnostic accuracy; Revised Sydney criteria

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; CONTROLLED STUDY; CRYOGLOBULINEMIA; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SYPHILIS;

HEPATITIS C VIRUS;

EID: 69949138952     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04659.x     Document Type: Conference Paper

References (24)

1. Hughes, G.R.V. 1983. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br. Med. J. 287: 1088-1089.
2. deGroot, P.G., J.D. Oosting, R.H.W.M. Derksen, et al. 1993. Antiphospholipid antibodies: specificity and pathophysiology. Bailliers Clin. Haematol. 6: 691-709.
3. McNeil H.P., R.J. Simpson, C.N. Chesterman, et al. 1990. Anti-phospholipid antibodies are directed against complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycopotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87: 4120-4124.
4. Galli, M., P. Comfurius, C. Maasen, et al. 1990. An-ticardiolipin antibodies (ACA) directed not to cardi-olipin but to a plasma protein cofactor. Lancet 335: 1544-1547.
5. Matsuura, E., Y. Igarashi, K. Fujimoto, et al. 1990. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177.
6. Viard, J.P., Z. Amoura & J.F. Bach. 1995. Anti-β2-glycoprotein I antibodies and thrombosis. Clin. Rev. Allergy Immunol. 13: 67-72.
7. Cabiedes, J., A.R. Cabral & D. Alarcon-Segovia. 1995. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythemato-sus associate more strongly with anti-β2-glycoprotein I than with antiphospholipid antibodies. J. Rheumatol. 22: 1899-1906.
8. Wilson W.A., A.E. Gharavi, T. Koike, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 42: 1309-1311.
9. Miyakis S. M.D. Lockshin T. Atsumi, et al. 2006. International consensus statement o an update of the classification criteria for definite antiphospho-lipid syndrome (APS). J. Thromb. Haemost. 4: 295-306.
10. Neville, C., J. Rauch, J. Kassis, et al. 2003. Throm-boembolic risk in patients with high titre anti-cardiolipin and multiple antiphospholipid antibodies. Thromb. Haemost. 90: 108-15.
11. Lee, E.Y., C.K. Lee, T. H. Lee, et al. Does the anti-β2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb. Res. 111: 29-32.
12. Galli, M., G. Borrelli, E.M. Jacobsen, et al. 2003. Antiβ2- glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 102: 2717-2723.
13. Favaloro, E.J., R.C.W. Wong, R. Silvestrini, et al. 2005. A multilaboratory peer assessment quality assurance program-based evaluation for anticardi-olipin antibody, and beta2-glycoprotein I antibody testing. Sem. Thromb. Hemost. 31: 73-84.
14. Pengo, V., A. Biasiolo, E. Bison, et al. 2007. An-tiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purifid IgG with anticardiolipin and anti-β2- glycoprotein I activity. Thromb. Res. 120: 127-133.
15. de Groot, P.G., R.H.W.M. Derksen & B. De Laat. 2008. Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospho-lipid syndrome. Semin. Thromb. Res. 34: 347-355.
16. Andreoli, L., S. Rizzini, F. Allegri, et al. 2008. Are the current attempts at standardization of antiphospho-lipid antibodies still useful? Emerging technologies signal a shift in direction. Semin. Thromb. Hemost. 34: 356-360.
17. Harris, E.N., A.E. Gharavi, S. Patel, et al. 1986. Evaluation of anti-cardiolipin antibody test: report of an international workshop held April 4 1986. Clin. Exp. Immunol. 68: 215-222.
18. Pengo, V., A. Ruffatti, S. Iliceto. 2006. The diagnosis of the antiphospholipid syndrome. J. Pathophysiol. Haemost. Thromb. 35: 175-180.
19. Tincani A., F. Allegri, M. Sanmarco, et al. 2001. An-ticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospho-lipid Forum. Thromb. Haemost. 86: 575-583.
20. Reber, G., A. Tincani, M. Sanmarco, et al. 2004. Proposal for the measurement of anti-β2-glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J. Thromb. Haemost. 2: 1860-1862.
21. Ruffatti, A., S. Olivieri, M. Tonello, et al. 2008. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J. Thromb. Haemost. 6: 1693-1696.
22. Wong, R.C.W. 2004. Consensus guidelines for anti-cardiolipin antibody resting. Thromb. Res. 114: 559-571.
23. Meroni, P.L. 2008. Pathogenesis of antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J. Autoimmun. 30: 99-103.
24. Reber, G., F. Boehlen & P. Moerloose. 2008. technical aspects in laboratory testing for antiphospholipid antibodies: Is standardization an impossible dream? Semin. Thromb. Hemost. 34: 340-346.